These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 24581840)

  • 1. [The quadrivalent vaccines against seasonal influenza. Are the ultimate solution?].
    Reina J
    Med Clin (Barc); 2014 Apr; 142(8):355-7. PubMed ID: 24581840
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccine production: potential engineering approaches to pandemic influenza.
    Harding CV; Heuer AH
    J Pharm Sci; 2007 Nov; 96(11):2879-85. PubMed ID: 17721947
    [No Abstract]   [Full Text] [Related]  

  • 3. Recommendation for the composition of influenza virus vaccines for use in 1999.
    Wkly Epidemiol Rec; 1998 Oct; 73(40):305-8. PubMed ID: 9787645
    [No Abstract]   [Full Text] [Related]  

  • 4. Recommended composition of influenza virus vaccines for use in the 1999-2000 season.
    Wkly Epidemiol Rec; 1999 Feb; 74(8):57-61. PubMed ID: 10079754
    [No Abstract]   [Full Text] [Related]  

  • 5. Recommended composition of influenza virus vaccines for use in the 2014-2015 northern hemisphere influenza season.
    Wkly Epidemiol Rec; 2014 Mar; 89(10):93-104. PubMed ID: 24707514
    [No Abstract]   [Full Text] [Related]  

  • 6. Prospects for broadly protective influenza vaccines.
    Treanor JJ
    Vaccine; 2015 Nov; 33 Suppl 4():D39-45. PubMed ID: 26338145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of the BD Directigen Flu A+B rapid antigen detection assay as an influenza outbreak detection tool.
    DeLima C; Blair J; Low DE; Burton L; Mazzulli T; Drews SJ
    Int J Infect Dis; 2009 Sep; 13(5):e327-8. PubMed ID: 19213587
    [No Abstract]   [Full Text] [Related]  

  • 8. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
    Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M
    J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flu in the limelight.
    Rimmelzwaan GF; Osterhaus AD
    Vaccine; 2002 May; 20(17-18):2153-4. PubMed ID: 12009266
    [No Abstract]   [Full Text] [Related]  

  • 10. Influenza. Antigenic analysis of recent influenza virus isolates.
    Wkly Epidemiol Rec; 1993 Sep; 68(39):288. PubMed ID: 8217585
    [No Abstract]   [Full Text] [Related]  

  • 11. Influenza vaccines.
    Wkly Epidemiol Rec; 2005 Aug; 80(33):279-87. PubMed ID: 16171031
    [No Abstract]   [Full Text] [Related]  

  • 12. Recommended composition of influenza virus vaccines for use in the 2010 influenza season (southern hemisphere winter).
    Wkly Epidemiol Rec; 2009 Oct; 84(41):421-31. PubMed ID: 19817019
    [No Abstract]   [Full Text] [Related]  

  • 13. Recommended composition of influenza virus vaccines for use in the 1990-1991 season.
    Wkly Epidemiol Rec; 1990 Feb; 65(8):53-6. PubMed ID: 2386721
    [No Abstract]   [Full Text] [Related]  

  • 14. [The antigenic-immunogenic activity of the trivalent polymer-subunit influenza vaccine Grippol in a controlled epidemiological trial (2)].
    El'shina GA; Masalin IuM; Shervarli VI; Gorbunov MA; Lonskaia NI; Agafonova LV; Khaitov RM; Nekrasov AV; Ivanova AS
    Voen Med Zh; 1996 Nov; 317(11):53-5. PubMed ID: 9036633
    [No Abstract]   [Full Text] [Related]  

  • 15. [The results of a study of the data obtained from patients vaccinated earlier with different influenza vaccines].
    Ivanova VT; Slepushkin AN; Burtseva EI; Oskerko TA; Golubeva LI; Beliaev AL
    Vopr Virusol; 1994; 39(2):66-8. PubMed ID: 8017055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The 2003/2004 influenza season in the Netherlands with a limited epidemic of the virus variant A/Fujian, and the vaccine composition for the 2004/2005 season].
    Rimmelzwaan GF; de Jong JC; Bartelds AI; Wilbrink B; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2004 Oct; 148(40):1984-8. PubMed ID: 15524136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From the Centers for Disease Control and Prevention. Update: influenza activity--United States and worldwide, 1993.
    JAMA; 1993 Oct; 270(15):1789, 1792. PubMed ID: 8411511
    [No Abstract]   [Full Text] [Related]  

  • 18. From the Centers for Disease Control and Prevention. Update: influenza activity--United States and worldwide, 1993-94 season, and composition of the 1994-95 influenza vaccine.
    JAMA; 1994 Apr; 271(14):1070-1. PubMed ID: 8151839
    [No Abstract]   [Full Text] [Related]  

  • 19. From the Centers for Disease Control and Prevention. Update: influenza activity--United States and worldwide, 1996-97 season, and composition of the 1997-98 influenza vaccine.
    JAMA; 1997 Jun; 277(21):1666-7. PubMed ID: 9169882
    [No Abstract]   [Full Text] [Related]  

  • 20. Update on influenza activity--United States and worldwide, with recommendations for influenza vaccine composition for the 1988-89 season.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1988 Apr; 37(15):241-4. PubMed ID: 3127677
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.